Global Hospital-acquired Infections (HAIs) Control Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Published on 08/24/2021| Code: MAR41115D| Category: Utilities| Total Pages: 121
Based on the Hospital-acquired Infections (HAIs) Control market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Hospital-acquired Infections (HAIs) Control market covered in Chapter 5:
Pfizer
Advanced Sterilization Products Division
STERIS Corporation
Becton Dickinson
Hoffmann-La Roche
In Chapter 6, on the basis of types, the Hospital-acquired Infections (HAIs) Control market from 2015 to 2025 is primarily split into:
Diagnostic Techniques
Dleaning and Sterilization
Treatment
In Chapter 7, on the basis of applications, the Hospital-acquired Infections (HAIs) Control market from 2015 to 2025 covers:
General Hospital
Infectious Disease Hospital
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Hospital-acquired Infections (HAIs) Control Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Pfizer
5.1.1 Pfizer Company Profile
5.1.2 Pfizer Business Overview
5.1.3 Pfizer Hospital-acquired Infections (HAIs) Control Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Pfizer Hospital-acquired Infections (HAIs) Control Products Introduction
5.2 Advanced Sterilization Products Division
5.2.1 Advanced Sterilization Products Division Company Profile
5.2.2 Advanced Sterilization Products Division Business Overview
5.2.3 Advanced Sterilization Products Division Hospital-acquired Infections (HAIs) Control Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Advanced Sterilization Products Division Hospital-acquired Infections (HAIs) Control Products Introduction
5.3 STERIS Corporation
5.3.1 STERIS Corporation Company Profile
5.3.2 STERIS Corporation Business Overview
5.3.3 STERIS Corporation Hospital-acquired Infections (HAIs) Control Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 STERIS Corporation Hospital-acquired Infections (HAIs) Control Products Introduction
5.4 Becton Dickinson
5.4.1 Becton Dickinson Company Profile
5.4.2 Becton Dickinson Business Overview
5.4.3 Becton Dickinson Hospital-acquired Infections (HAIs) Control Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Becton Dickinson Hospital-acquired Infections (HAIs) Control Products Introduction
5.5 Hoffmann-La Roche
5.5.1 Hoffmann-La Roche Company Profile
5.5.2 Hoffmann-La Roche Business Overview
5.5.3 Hoffmann-La Roche Hospital-acquired Infections (HAIs) Control Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Hoffmann-La Roche Hospital-acquired Infections (HAIs) Control Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Hospital-acquired Infections (HAIs) Control Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Hospital-acquired Infections (HAIs) Control Sales and Market Share by Types (2015-2020)
6.1.2 Global Hospital-acquired Infections (HAIs) Control Revenue and Market Share by Types (2015-2020)
6.1.3 Global Hospital-acquired Infections (HAIs) Control Price by Types (2015-2020)
6.2 Global Hospital-acquired Infections (HAIs) Control Market Forecast by Types (2020-2025)
6.2.1 Global Hospital-acquired Infections (HAIs) Control Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Hospital-acquired Infections (HAIs) Control Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Hospital-acquired Infections (HAIs) Control Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Hospital-acquired Infections (HAIs) Control Sales, Price and Growth Rate of Diagnostic Techniques
6.3.2 Global Hospital-acquired Infections (HAIs) Control Sales, Price and Growth Rate of Dleaning and Sterilization
6.3.3 Global Hospital-acquired Infections (HAIs) Control Sales, Price and Growth Rate of Treatment
6.4 Global Hospital-acquired Infections (HAIs) Control Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Diagnostic Techniques Market Revenue and Sales Forecast (2020-2025)
6.4.2 Dleaning and Sterilization Market Revenue and Sales Forecast (2020-2025)
6.4.3 Treatment Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Hospital-acquired Infections (HAIs) Control Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Hospital-acquired Infections (HAIs) Control Sales and Market Share by Applications (2015-2020)
7.1.2 Global Hospital-acquired Infections (HAIs) Control Revenue and Market Share by Applications (2015-2020)
7.2 Global Hospital-acquired Infections (HAIs) Control Market Forecast by Applications (2020-2025)
7.2.1 Global Hospital-acquired Infections (HAIs) Control Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Hospital-acquired Infections (HAIs) Control Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Hospital-acquired Infections (HAIs) Control Revenue, Sales and Growth Rate of General Hospital (2015-2020)
7.3.2 Global Hospital-acquired Infections (HAIs) Control Revenue, Sales and Growth Rate of Infectious Disease Hospital (2015-2020)
7.4 Global Hospital-acquired Infections (HAIs) Control Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 General Hospital Market Revenue and Sales Forecast (2020-2025)
7.4.2 Infectious Disease Hospital Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Hospital-acquired Infections (HAIs) Control Sales by Regions (2015-2020)
8.2 Global Hospital-acquired Infections (HAIs) Control Market Revenue by Regions (2015-2020)
8.3 Global Hospital-acquired Infections (HAIs) Control Market Forecast by Regions (2020-2025)
9 North America Hospital-acquired Infections (HAIs) Control Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Hospital-acquired Infections (HAIs) Control Market Sales and Growth Rate (2015-2020)
9.3 North America Hospital-acquired Infections (HAIs) Control Market Revenue and Growth Rate (2015-2020)
9.4 North America Hospital-acquired Infections (HAIs) Control Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Hospital-acquired Infections (HAIs) Control Market Analysis by Country
9.6.1 U.S. Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
9.6.2 Canada Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
9.6.3 Mexico Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
10 Europe Hospital-acquired Infections (HAIs) Control Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Hospital-acquired Infections (HAIs) Control Market Sales and Growth Rate (2015-2020)
10.3 Europe Hospital-acquired Infections (HAIs) Control Market Revenue and Growth Rate (2015-2020)
10.4 Europe Hospital-acquired Infections (HAIs) Control Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Hospital-acquired Infections (HAIs) Control Market Analysis by Country
10.6.1 Germany Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
10.6.2 United Kingdom Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
10.6.3 France Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
10.6.4 Italy Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
10.6.5 Spain Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
10.6.6 Russia Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
11 Asia-Pacific Hospital-acquired Infections (HAIs) Control Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Hospital-acquired Infections (HAIs) Control Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Hospital-acquired Infections (HAIs) Control Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Hospital-acquired Infections (HAIs) Control Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Hospital-acquired Infections (HAIs) Control Market Analysis by Country
11.6.1 China Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
11.6.2 Japan Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
11.6.3 South Korea Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
11.6.4 Australia Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
11.6.5 India Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
12 South America Hospital-acquired Infections (HAIs) Control Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Hospital-acquired Infections (HAIs) Control Market Sales and Growth Rate (2015-2020)
12.3 South America Hospital-acquired Infections (HAIs) Control Market Revenue and Growth Rate (2015-2020)
12.4 South America Hospital-acquired Infections (HAIs) Control Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Hospital-acquired Infections (HAIs) Control Market Analysis by Country
12.6.1 Brazil Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
12.6.2 Argentina Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
12.6.3 Columbia Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
13 Middle East and Africa Hospital-acquired Infections (HAIs) Control Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Hospital-acquired Infections (HAIs) Control Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Hospital-acquired Infections (HAIs) Control Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Hospital-acquired Infections (HAIs) Control Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Hospital-acquired Infections (HAIs) Control Market Analysis by Country
13.6.1 UAE Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
13.6.2 Egypt Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
13.6.3 South Africa Hospital-acquired Infections (HAIs) Control Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
Speak to Our Industry Expert
Our Clients
.png)
Need Help?
Please fill form below:
Call Us
USA: +1(929)-450-2887
USA: +1(650)-666-4592
Email Us
Contact Us
99 WALL STREET #2124 NEW YORK, NY 10005